Skip to main content
. 2019 Dec 27;9:20047. doi: 10.1038/s41598-019-56377-z

Table 1.

Identification of somatic mutation in CSC.

Gene name Sample HGVS c. HGVS p. Depth Variant read VAF (%)
KMT2B FFPE c.7804 A > G p.Ile2602Val 1692 221 13.1
CSC c.7804 A > G p.Ile2602Val 122760 42845 34.9
cfDNA c.7804 A > G p.Ile2602Val 570143 1028 0.18
c.7804 A > C p.Ile2602Leu 66 0.011
c.7804 A > T p.Ile2602Phe 87 0.015

cfDNA

(GCTB-1)

c.7804 A > G p.Ile2602Val 694481 1343 0.19
c.7804 A > C p.Ile2602Leu 94 0.013
c.7804 A > T p.Ile2602Phe 64 0.0092

cfDNA

(GCTB-2)

c.7804 A > G p.Ile2602Val 692495 1412 0.20
c.7804 A > C p.Ile2602Leu 76 0.0098
c.7804 A > T p.Ile2602Phe 63 0.0090
MGA FFPE c.3628 C > G p.Arg1210Gly 588 36 6.12
CSC, cfDNA c.3628 C > G p.Arg1210Gly NA NA NA

HGVS, Human Genome Variation Society; c., coding DNA sequence; p., protein sequence; VAF, variant allele frequency.

FFPE, formalin-fixed paraffin-embedded; CSC, circulating sarcoma cell; cfDNA, cell-free DNA; GCTB, giant cell tumor of bone; NA, not applied.